|
|
Article: Appointments And Advancements.(Aldagen Inc. appointing David P. Carberry as chief financial officer)(AMAG Pharmaceuticals Inc. appointing Joseph V. Bonventre to its board)(Catalyst Pharmaceutical Partners Inc. appointing Patrick Kenny director of corporate clinical compliance.)
- Article from:
- BIOWORLD Today
- Article date:
- March 17, 2008
CopyrightCOPYRIGHT 2008 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Adnavance Technologies Inc., of San Diego, appointed Anthony P. Bihl III to its board.
Aldagen Inc., of Durham, N.C., appointed David P. Carberry chief financial officer.
Alexza Pharmaceuticals Inc., of Mountain View, Calif., named Michael J. Simms senior vice president of operations and manufacturing.
Algeta ASA, of Oslo, Norway, appointed Hellek Br=E5then interim chief financial officer.
AMAG Pharmaceuticals Inc., of Cambridge, Mass., appointed Joseph V. Bonventre to its board.
Ambit Biosciences, of San Diego, named Jorge Cortes, Brian Druker, Gary Gilliland and Mark Levis to its hematology and oncology clinical advisory ...